Jump to main content
Jump to site search

Issue 16, 2011
Previous Article Next Article

Mesoporous silica nanoparticle based nano drug delivery systems: synthesis, controlled drug release and delivery, pharmacokinetics and biocompatibility

Author affiliations

Abstract

The biomedical applications of mesoporous silica nanoparticles (MSNs) as efficient drug delivery carriers have attracted great attention in the last decade. The structure, morphology, size, and surface properties of MSNs have been found to be facilely tunable for the purposes of drug loading, controlled drug release and delivery, and multifuctionalization. Meanwhile, the biosafety and in vivo drug efficiency of MSN-based nano drug delivery systems (nano-DDSs), involving biocompatibility (including cytotoxicity, blood and tissue compatibility) and pharmacokinetics (including biodistribution, biodegradation, retention, excretion, blood circulation) are also drawing increasing attention because of their clinical application prospects. Herein, we review the most recent research progresses on the synthesis, controlled drug release and delivery, pharmacokinetics and biocompatibility of MSNs.

Graphical abstract: Mesoporous silica nanoparticle based nano drug delivery systems: synthesis, controlled drug release and delivery, pharmacokinetics and biocompatibility

Back to tab navigation

Publication details

The article was received on 09 Nov 2010, accepted on 11 Jan 2011 and first published on 24 Feb 2011


Article type: Feature Article
DOI: 10.1039/C0JM03851B
Citation: J. Mater. Chem., 2011,21, 5845-5855
  •   Request permissions

    Mesoporous silica nanoparticle based nano drug delivery systems: synthesis, controlled drug release and delivery, pharmacokinetics and biocompatibility

    Q. He and J. Shi, J. Mater. Chem., 2011, 21, 5845
    DOI: 10.1039/C0JM03851B

Search articles by author

Spotlight

Advertisements